Prognostic factors in soft tissue sarcoma. A review and the Scandinavian Sarcoma Group experience.
Rydholm
A
A
University Hospital, Lund, Sweden.
Gustafson
P
P
Alvegård
T A
TA
Saeter
G
G
Blomqvist
C
C
D014408:Biomarkers, Tumor; D002869:Chromosome Aberrations / Q000235:genetics; D025063:Chromosome Disorders; D004273:DNA, Neoplasm / Q000032:analysis; D016002:Discriminant Analysis; D006801:Humans; D009367:Neoplasm Staging / Q000379:methods*; D011379:Prognosis; D012042:Registries; D015203:Reproducibility of Results; D012307:Risk Factors; D012509:Sarcoma / Q000235:genetics* / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D012537:Scandinavian and Nordic Countries; D012680:Sensitivity and Specificity; D012983:Soft Tissue Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D016019:Survival Analysis
D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm